Sequence of events leading to primary biliary cholangitis
Open Access
- 7 October 2023
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 29 (37) , 5305-5312
Abstract
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease that is observed more frequently in middle-aged women. This disorder is considered an autoimmune disease, since liver injury is sustained by the presence of self-directed antimitochondrial antibodies targeting the bile duct cells. The prognosis may vary depending on an early diagnosis and response to therapy. However, nearly a third of patients can progress to liver cirrhosis, thus requiring a liver transplant. Traditional immunosuppressive therapies, commonly employed for other autoimmune diseases, have limited effects on PBC. In fact, dramatic functional changes that occur in the biliary epithelium in the course of inflammation play a major role in perpetuating the injury. In this minireview, after a background on the disease and possible predisposing factors, the sequential cooperation of cellular/molecular events leading to end-stage PBC is discussed in detail. The rise and maintenance of the autoimmune process, as well as the response of the biliary epithelia during inflammatory injury, are key factors in the progression of the disease. The so-called “ductular reaction (DR)”, intended as a reactive expansion of cells with biliary phenotype, is a process frequently observed in PBC and partially understood. However, recent findings suggest a strict relationship between this pathological picture and the progression to liver fibrosis, cell senescence, and loss of biliary ducts. All these issues (onset of chronic inflammation, changes in secretive and proliferative biliary functions, DR, and its relationship with other pathological events) are discussed in this manuscript in an attempt to provide a snapshot, for clinicians and researchers, of the most relevant and sequential contributors to the progression of this human cholestatic disease. We believe that interpreting this disorder as a multistep process may help identify possible therapeutic targets to prevent evolution to severe disease.Keywords
This publication has 58 references indexed in Scilit:
- Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signalingAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2013
- Autophagy May Precede Cellular Senescence of Bile Ductular Cells in Ductular Reaction in Primary Biliary CirrhosisDigestive Diseases and Sciences, 2011
- Human leukocyte antigen in primary biliary cirrhosis: An old story now revivingHepatology, 2011
- Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosisHepatology, 2011
- Genetics and Genomics of Primary Biliary CirrhosisClinics in Liver Disease, 2008
- Ae2-Deficient Mice Develop Antimitochondrial Antibodies and Other Features Resembling Primary Biliary CirrhosisGastroenterology, 2008
- Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct lossThe Journal of Pathology, 2005
- cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathwayJournal of Hepatology, 2004
- Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human liversHepatology, 2004
- Mitochondrial antigens, molecular mimicry and autoimmune diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995